Zobrazeno 1 - 10
of 1 687
pro vyhledávání: '"Radimerski, T."'
Autor:
Schröder M; Novartis Institutes for BioMedical Research, Basel, Switzerland. martin-1.schroeder@novartis.com., Renatus M; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland., Liang X; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Meili F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Zoller T; Novartis Institutes for BioMedical Research, Basel, Switzerland., Ferrand S; Novartis Institutes for BioMedical Research, Basel, Switzerland., Gauter F; Novartis Institutes for BioMedical Research, Basel, Switzerland., Li X; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Sigoillot F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Gleim S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Stachyra TM; Novartis Institutes for BioMedical Research, Basel, Switzerland., Thomas JR; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Begue D; Novartis Institutes for BioMedical Research, Basel, Switzerland., Khoshouei M; Novartis Institutes for BioMedical Research, Basel, Switzerland., Lefeuvre P; Novartis Institutes for BioMedical Research, Basel, Switzerland., Andraos-Rey R; Novartis Institutes for BioMedical Research, Basel, Switzerland., Chung B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Ma R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Pinch B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Hofmann A; Novartis Institutes for BioMedical Research, Basel, Switzerland., Schirle M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Schmiedeberg N; Novartis Institutes for BioMedical Research, Basel, Switzerland., Imbach P; Novartis Institutes for BioMedical Research, Basel, Switzerland., Gorses D; Novartis Institutes for BioMedical Research, Basel, Switzerland., Calkins K; Novartis Institutes for BioMedical Research, Basel, Switzerland., Bauer-Probst B; Novartis Institutes for BioMedical Research, Basel, Switzerland., Maschlej M; Novartis Institutes for BioMedical Research, Basel, Switzerland., Niederst M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Maher R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Henault M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Alford J; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Ahrne E; Novartis Institutes for BioMedical Research, Basel, Switzerland., Tordella L; Novartis Institutes for BioMedical Research, Basel, Switzerland., Hollingworth G; Novartis Institutes for BioMedical Research, Basel, Switzerland., Thomä NH; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Swiss Institute for Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Vulpetti A; Novartis Institutes for BioMedical Research, Basel, Switzerland., Radimerski T; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland., Holzer P; Novartis Institutes for BioMedical Research, Basel, Switzerland., Carbonneau S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Thoma CR; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. cthoma@ridgelinediscovery.com.; Ridgeline Discovery, Basel, Switzerland. cthoma@ridgelinediscovery.com.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 19; Vol. 15 (1), pp. 7109. Date of Electronic Publication: 2024 Aug 19.
Autor:
Zhang A; Global Discovery Chemistry, Novartis Biomedical Research, Cambridge, Massachusetts 02139 United States., Seiss K; Oncology Biotherapeutics, Novartis Biomedical Research, Cambridge, Massachusetts 02139 United States., Laborde L; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland., Palacio-Ramirez S; Novartis Biologics Center, Novartis Biomedical Research, Cambridge, Massachusetts 02139 United States., Guthy D; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland., Lanter M; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland., Lorber J; Global Discovery Chemistry, Novartis Biomedical Research, CH-4002 Basel, Switzerland., Vulpetti A; Global Discovery Chemistry, Novartis Biomedical Research, CH-4002 Basel, Switzerland., Arista L; Global Discovery Chemistry, Novartis Biomedical Research, CH-4002 Basel, Switzerland., Zoller T; Global Discovery Chemistry, Novartis Biomedical Research, CH-4002 Basel, Switzerland., Radimerski T; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland., Thoma C; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland., Hebach C; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland., Tschantz WR; Novartis Biologics Center, Novartis Biomedical Research, Cambridge, Massachusetts 02139 United States., Karpov A; Global Discovery Chemistry, Novartis Biomedical Research, CH-4002 Basel, Switzerland., Hollingworth GJ; Global Discovery Chemistry, Novartis Biomedical Research, CH-4002 Basel, Switzerland., D'Alessio JA; Oncology Biotherapeutics, Novartis Biomedical Research, Cambridge, Massachusetts 02139 United States., Ferretti S; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland., Burger MT; Global Discovery Chemistry, Novartis Biomedical Research, Cambridge, Massachusetts 02139 United States.
Publikováno v:
Bioconjugate chemistry [Bioconjug Chem] 2024 Feb 21; Vol. 35 (2), pp. 140-146. Date of Electronic Publication: 2024 Jan 24.
Autor:
Schröder M; Novartis Institutes for BioMedical Research, Basel, Switzerland. martin-1.schroeder@novartis.com., Renatus M; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland., Liang X; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Meili F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Zoller T; Novartis Institutes for BioMedical Research, Basel, Switzerland., Ferrand S; Novartis Institutes for BioMedical Research, Basel, Switzerland., Gauter F; Novartis Institutes for BioMedical Research, Basel, Switzerland., Li X; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Sigoillot F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Gleim S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Stachyra TM; Novartis Institutes for BioMedical Research, Basel, Switzerland., Thomas JR; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Begue D; Novartis Institutes for BioMedical Research, Basel, Switzerland., Khoshouei M; Novartis Institutes for BioMedical Research, Basel, Switzerland., Lefeuvre P; Novartis Institutes for BioMedical Research, Basel, Switzerland., Andraos-Rey R; Novartis Institutes for BioMedical Research, Basel, Switzerland., Chung B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Ma R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Pinch B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Hofmann A; Novartis Institutes for BioMedical Research, Basel, Switzerland., Schirle M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Schmiedeberg N; Novartis Institutes for BioMedical Research, Basel, Switzerland., Imbach P; Novartis Institutes for BioMedical Research, Basel, Switzerland., Gorses D; Novartis Institutes for BioMedical Research, Basel, Switzerland., Calkins K; Novartis Institutes for BioMedical Research, Basel, Switzerland., Bauer-Probst B; Novartis Institutes for BioMedical Research, Basel, Switzerland., Maschlej M; Novartis Institutes for BioMedical Research, Basel, Switzerland., Niederst M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Maher R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Henault M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Alford J; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Ahrne E; Novartis Institutes for BioMedical Research, Basel, Switzerland., Tordella L; Novartis Institutes for BioMedical Research, Basel, Switzerland., Hollingworth G; Novartis Institutes for BioMedical Research, Basel, Switzerland., Thomä NH; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Swiss Institute for Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Vulpetti A; Novartis Institutes for BioMedical Research, Basel, Switzerland., Radimerski T; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland., Holzer P; Novartis Institutes for BioMedical Research, Basel, Switzerland., Carbonneau S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Thoma CR; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. cthoma@ridgelinediscovery.com.; Ridgeline Discovery, Basel, Switzerland. cthoma@ridgelinediscovery.com.
Publikováno v:
Nature communications [Nat Commun] 2024 Jan 04; Vol. 15 (1), pp. 275. Date of Electronic Publication: 2024 Jan 04.
Autor:
Vulpetti A; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Holzer P; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Schmiedeberg N; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Imbach-Weese P; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Pissot-Soldermann C; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Hollingworth GJ; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Radimerski T; Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Thoma CR; Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Stachyra TM; Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Wojtynek M; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Maschlej M; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Chau S; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Schuffenhauer A; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Fernández C; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Schröder M; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland., Renatus M; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel 4002, Switzerland.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2023 Jun 02; Vol. 14 (7), pp. 949-954. Date of Electronic Publication: 2023 Jun 02 (Print Publication: 2023).
Autor:
Vulin M; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Jehanno C; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., Sethi A; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland., Correia AL; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Obradović MMS; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Couto JP; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Coissieux MM; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Diepenbruck M; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., Preca BT; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., Volkmann K; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., der Maur PA; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., Schmidt A; Proteomics Core Facility, Biozentrum, University of Basel, Basel, Switzerland., Münst S; Institute of Pathology and Medical Genetics, University Hospital Basel, University of Basel, Basel, Switzerland., Sauteur L; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., Kloc M; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland., Palafox M; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland., Britschgi A; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Unterreiner V; Novartis Institutes for Biomedical Research, Basel, Switzerland., Galuba O; Novartis Institutes for Biomedical Research, Basel, Switzerland., Claerr I; Novartis Institutes for Biomedical Research, Basel, Switzerland., Lopez-Romero S; Novartis Institutes for Biomedical Research, Basel, Switzerland., Galli GG; Novartis Institutes for Biomedical Research, Basel, Switzerland., Baeschlin D; Novartis Institutes for Biomedical Research, Basel, Switzerland., Okamoto R; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Soysal SD; Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Breast Cancer Center, University Hospital Basel, University of Basel, Basel, Switzerland., Mechera R; Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Breast Cancer Center, University Hospital Basel, University of Basel, Basel, Switzerland., Weber WP; Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Breast Cancer Center, University Hospital Basel, University of Basel, Basel, Switzerland., Radimerski T; Novartis Institutes for Biomedical Research, Basel, Switzerland., Bentires-Alj M; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland. m.bentires-alj@unibas.ch.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. m.bentires-alj@unibas.ch.
Publikováno v:
Oncogene [Oncogene] 2022 Sep; Vol. 41 (39), pp. 4459-4473. Date of Electronic Publication: 2022 Aug 25.
Autor:
Casado-García A; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Isidro-Hernández M; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Oak N; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Mayado A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Servicio de Citometría, Departamento de Medicina, Biomedical Research Networking Centre on Cancer CIBER-CIBERONC (CB16/12/00400), Institute of Health Carlos III, and Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Salamanca, Spain., Mann-Ran C; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland., Raboso-Gallego J; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Alemán-Arteaga S; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Buhles A; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland., Sterker D; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland., Sánchez EG; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain., Martínez-Cano J; Immune system development and function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain., Blanco O; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Departamento de Anatomía Patológica, Universidad de Salamanca, Salamanca, Spain., Orfao A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Servicio de Citometría, Departamento de Medicina, Biomedical Research Networking Centre on Cancer CIBER-CIBERONC (CB16/12/00400), Institute of Health Carlos III, and Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Salamanca, Spain., Alonso-López D; Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain., De Las Rivas J; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Bioinformatics and Functional Genomics Research Group, Cancer Research Center (CSIC-USAL), Salamanca, Spain., Riesco S; Department of Pediatrics, Hospital Universitario de Salamanca, Paseo de San Vicente, 58-182, Salamanca, Spain., Prieto-Matos P; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Pediatrics, Hospital Universitario de Salamanca, Paseo de San Vicente, 58-182, Salamanca, Spain., González-Murillo Á; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain., García Criado FJ; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Departamento de Cirugía, Universidad de Salamanca, Salamanca, Spain., García Cenador MB; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Departamento de Cirugía, Universidad de Salamanca, Salamanca, Spain., Radimerski T; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland., Ramírez-Orellana M; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain., Cobaleda C; Immune system development and function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain., Yang JJ; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee., Vicente-Dueñas C; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Pediatrics, Hospital Universitario de Salamanca, Paseo de San Vicente, 58-182, Salamanca, Spain., Weiss A; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland., Nichols KE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Sánchez-García I; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Publikováno v:
Cancer research [Cancer Res] 2022 Mar 15; Vol. 82 (6), pp. 1098-1109.
Autor:
Radimerski T, Michal Schwarz, Manley Pw, Peggy Grille, Frauke Ringel, Marque F, le Coutre P, Bernd Dörken, Jaspal Kaeda, Christian Oberender
Publikováno v:
Acta Haematologica. 132:75-86
Janus kinases are critical components of signaling pathways that regulate hematopoiesis. Mutations of the non-receptor tyrosine kinase JAK2 are found in many BCR-ABL-negative myeloproliferative neoplasms. Preclinical results support that JAK2 inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9990de3375ce56d0ca842fda9b934e17
https://doi.org/10.1159/000356784
https://doi.org/10.1159/000356784
Autor:
Kharrat, Bayan1 (AUTHOR), Gábor, Erika1 (AUTHOR), Virág, Nikolett2 (AUTHOR), Sinka, Rita3 (AUTHOR), Jankovics, Ferenc4 (AUTHOR), Kristó, Ildikó5 (AUTHOR), Vilmos, Péter5 (AUTHOR), Csordás, Gábor6 (AUTHOR), Honti, Viktor1 (AUTHOR) honti.viktor@brc.hu
Publikováno v:
PLoS Genetics. 10/28/2024, Vol. 20 Issue 10, p1-25. 25p.
Autor:
Zang, Shuting1,2,3 (AUTHOR), Wang, Ruijuan1,2 (AUTHOR), Liu, Yan1,2 (AUTHOR), Zhao, Shan1,2 (AUTHOR), Su, Long1,2 (AUTHOR), Dai, Xiaoyan1,2 (AUTHOR), Chen, Hao1,2 (AUTHOR), Yin, Zhenjuan1,2 (AUTHOR), Zheng, Li1,2 (AUTHOR), Liu, Qingxin3 (AUTHOR) liuqingxin@sdau.edu.cn, Zhai, Yifan1,2 (AUTHOR) liuqingxin@sdau.edu.cn
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 19, p10441. 18p.
Autor:
Quancard J; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Simic O; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Pissot Soldermann C; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Aichholz R; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Blatter M; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Renatus M; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Erbel P; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Melkko S; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Endres R; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Sorge M; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Kieffer L; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Wagner T; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Beltz K; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Mcsheehy P; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Wartmann M; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Régnier CH; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Calzascia T; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Radimerski T; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Bigaud M; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Weiss A; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Bornancin F; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland., Schlapbach A; Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2020 Dec 10; Vol. 63 (23), pp. 14594-14608. Date of Electronic Publication: 2020 Nov 20.